Ardelyx (ARDX) Earnings Date, Estimates & Call Transcripts → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free ARDX Stock Alerts $6.44 -0.11 (-1.68%) (As of 04/18/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 2After Market ClosesConfirmedActual EPS (Feb. 22) -$0.12 Missed By -$0.03 Consensus EPS (Feb. 22) -$0.09 Read Call TranscriptListen to Call Get Ardelyx Earnings AlertsEnter your email address below to receive the latest news and earnings results for ARDX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueARDX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ARDX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Priority GoldBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...Get your free information kit NOW, before it's too late. Ardelyx Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.10)($0.08)($0.09)Q2 20242($0.09)($0.06)($0.08)Q3 20242($0.05)($0.03)($0.04)Q4 20242($0.02)$0.00($0.01)FY 20248($0.26)($0.17)($0.22)Q4 20251$0.14$0.14$0.14ARDX Earnings Date and InformationArdelyx last posted its earnings results on February 22nd, 2024. The biopharmaceutical company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by $0.03. The firm had revenue of $34.36 million for the quarter, compared to analysts' expectations of $34.26 million. Its revenue for the quarter was down 22.2% on a year-over-year basis. Ardelyx has generated ($0.30) earnings per share over the last year (($0.30) diluted earnings per share). Earnings for Ardelyx are expected to grow in the coming year, from ($0.44) to $0.10 per share. Ardelyx has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off prior year's report dates.Read More Ardelyx Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/2/2024Confirmed)------- 2/22/2024Q4 2023($0.09)($0.12)($0.03)($0.12)$34.26 million$34.36 million 10/31/2023Q3 2023($0.11)$0.03+$0.14$0.03$22.09 million$56.39 million8/2/2023Q2 2023($0.12)($0.08)+$0.04($0.08)$15.88 million$22.33 million5/3/2023Q1 2023($0.11)($0.13)($0.02)($0.13)$10.08 million$11.37 million 3/2/2023Q4 2022$0.01$0.06+$0.05$0.06$27.71 million$44.18 million11/3/2022Q3 2022($0.17)($0.14)+$0.03($0.14)$2.67 million$4.99 million Get the Latest News and Ratings for ARDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ardelyx and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022($0.19)($0.19)-($0.19)$0.62 million$2.53 million 5/5/2022Q1 2022($0.20)($0.21)($0.01)($0.21)$0.25 million$0.47 million 2/28/2022Q4 2021($0.25)($0.31)($0.06)($0.31)$2.00 million$1.03 million 11/12/2021Q3 2021($0.35)($0.42)($0.07)($0.42)$0.85 million$1.17 million8/12/2021Q2 2021($0.36)($0.45)($0.09)($0.45)$1.10 million$1.31 million5/5/2021Q1 2021($0.33)($0.34)($0.01)($0.34)$1.10 million$6.58 million Ardelyx Earnings - Frequently Asked Questions When is Ardelyx's earnings date? Ardelyx has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off last year's report dates. Learn more on ARDX's earnings history. Did Ardelyx beat their earnings estimates last quarter? In the previous quarter, Ardelyx (NASDAQ:ARDX) missed the analysts' consensus estimate of ($0.09) by $0.03 with a reported earnings per share (EPS) of ($0.12). Learn more on analysts' earnings estimate vs. ARDX's actual earnings. How can I listen to Ardelyx's earnings conference call? The conference call for Ardelyx's latest earnings report can be listened to online. Listen to Conference Call How can I read Ardelyx's conference call transcript? The conference call transcript for Ardelyx's latest earnings report can be read online. Read Transcript How much revenue does Ardelyx generate each year? Ardelyx (NASDAQ:ARDX) has a recorded annual revenue of $124.46 million. How much profit does Ardelyx generate each year? Ardelyx (NASDAQ:ARDX) has a recorded net income of -$66.07 million. ARDX has generated -$0.30 earnings per share over the last four quarters. What is Ardelyx's EPS forecast for next year? Ardelyx's earnings are expected to grow from ($0.44) per share to $0.10 per share in the next year. More Earnings Resources from MarketBeat Related Companies: Harmony Biosciences Earnings Supernus Pharmaceuticals Earnings Protagonist Therapeutics Earnings Geron Earnings Taro Pharmaceutical Industries Earnings Catalyst Pharmaceuticals Earnings Edgewise Therapeutics Earnings Amneal Pharmaceuticals Earnings Dynavax Technologies Earnings Agios Pharmaceuticals Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff? This page (NASDAQ:ARDX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ardelyx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.